NEW YORK (AP) _ Actinium Pharmaceuticals Inc. (ATNM) on Friday reported a loss of $5.3 million in its first quarter.

The New York-based company said it had a loss of 29 cents per share.

The cancer drug developer posted revenue of $622,000 in the period.

Actinium shares have dropped 9% since the beginning of the year. In the final minutes of trading on Friday, shares hit $7.09, an increase of 31% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNM at https://www.zacks.com/ap/ATNM

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News